Skip to main content

Peer Review reports

From: Fuzheng Kang’ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trial

Original Submission
18 Dec 2014 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Publishing
26 Mar 2015 Editorially accepted
10 Apr 2015 Article published 10.1186/s13063-015-0685-2

You can find further information about peer review here.

Back to article page